Status: current, Defined. Date: 30-Jun 2022. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
5048580016 | Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule | en | Synonym | Active | Case insensitive | SNOMED CT core |
5048581017 | Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline hydrochloride 125 milligram/1 each conventional release oral capsule (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule | Is a | Bismuth biskalcitrate and metronidazole and tetracycline only product in oral dose form | true | Inferred relationship | Some | ||
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule | Has manufactured dose form | Conventional release oral capsule | true | Inferred relationship | Some | ||
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule | Has unit of presentation | Capsule | true | Inferred relationship | Some | ||
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Some | ||
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule | Has precise active ingredient | Tetracycline hydrochloride | true | Inferred relationship | Some | 1 | |
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule | Has BoSS | Tetracycline hydrochloride | true | Inferred relationship | Some | 1 | |
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule | Has presentation strength denominator unit | Capsule | true | Inferred relationship | Some | 1 | |
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule | Has precise active ingredient | Metronidazole | true | Inferred relationship | Some | 2 | |
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule | Has BoSS | Metronidazole | true | Inferred relationship | Some | 2 | |
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule | Has presentation strength denominator unit | Capsule | true | Inferred relationship | Some | 2 | |
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule | Has precise active ingredient | Bismuth biskalcitrate | true | Inferred relationship | Some | 3 | |
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule | Has BoSS | Bismuth biskalcitrate | true | Inferred relationship | Some | 3 | |
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 3 | |
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule | Has presentation strength denominator unit | Capsule | true | Inferred relationship | Some | 3 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets